Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 108.41 USD 1.06% Market Closed
Market Cap: 22.1B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Wall Street
Price Targets

ZBH Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBH is 125.78 USD with a low forecast of 108.07 USD and a high forecast of 152.25 USD.

Lowest
Price Target
108.07 USD
0% Downside
Average
Price Target
125.78 USD
16% Upside
Highest
Price Target
152.25 USD
40% Upside

ZBH Last Price Targets
Zimmer Biomet Holdings Inc

The latest public price target was made on Oct 15, 2024 by Steven Lichtman from Oppenheimer , who expects ZBH stock to rise by 25% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Steven Lichtman
Oppenheimer
135 USD
Upside 25%
3 weeks ago
Oct 15, 2024
Zimmer Biomet (ZBH) PT Lowered to $135 at Oppenheimer
StreetInsider
Ryan Zimmerman
BTIG
126 USD
Upside 16%
1 month ago
Oct 3, 2024
Zimmer Biomet price target lowered to $126 from $134 at BTIG
TheFly
Vijay Kumar
Evercore ISI
110 USD
Upside 1%
1 month ago
Oct 1, 2024
Zimmer Biomet price target lowered to $110 from $113 at Evercore ISI
TheFly
Richard Newitter
Truist Financial
112 USD
Upside 3%
1 month ago
Sep 13, 2024
Zimmer Biomet price target lowered to $112 from $117 at Truist
TheFly
Caitlin Cronin
Canaccord Genuity
115 USD
Upside 6%
1 month ago
Sep 10, 2024
Zimmer Biomet price target lowered to $115 from $120 at Canaccord
TheFly
Steven Lichtman
Oppenheimer
145 USD
Upside 34%
2 months ago
Aug 8, 2024
Zimmer Biomet price target lowered to $145 from $155 at Oppenheimer
TheFly
Jayson Bedford
Raymond James
128 USD
Upside 18%
2 months ago
Aug 8, 2024
Zimmer Biomet price target lowered to $128 from $138 at Raymond James
TheFly
Rick Wise
Stifel Nicolaus
130 USD
Upside 20%
2 months ago
Aug 7, 2024
Zimmer Biomet price target lowered to $130 from $135 at Stifel
TheFly
Drew Ranieri
Morgan Stanley
120 USD
Upside 11%
3 months ago
Jul 15, 2024
Zimmer Biomet price target lowered to $120 from $130 at Morgan Stanley
TheFly
Matt O'Brien
Piper Sandler
115 USD
Upside 6%
4 months ago
Jul 1, 2024
Zimmer Biomet downgraded to Neutral from Overweight at Piper Sandler
TheFly
Matthew O\'Brien
Piper Sandler
140 USD
Upside 29%
5 months ago
May 31, 2024
Piper Sandler Reiterates Overweight Rating on Zimmer Biomet (ZBH)
StreetInsider
Shagun Singh
RBC Capital
140 USD
Upside 29%
5 months ago
May 30, 2024
RBC Capital Reiterates Outperform Rating on Zimmer Biomet (ZBH)
StreetInsider
Ryan Zimmerman
BTIG
139 USD
Upside 28%
5 months ago
May 28, 2024
BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH)
StreetInsider
David Toung
Argus Research
150 USD
Upside 38%
5 months ago
May 21, 2024
Argus Upgrades Zimmer Biomet (ZBH) to Buy
StreetInsider
Zimmer Biomet
Stifel Nicolaus
165 USD
Upside 52%
1 year ago
Sep 11, 2023
Financial Gravity Asset Management Inc. Purchases Shares of 129 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Defense World
Zimmer Biomet
Truist Financial
148 USD
Upside 37%
1 year ago
Sep 11, 2023
Financial Gravity Asset Management Inc. Purchases Shares of 129 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Defense World
Zimmer Biomet
UBS
125 USD
Upside 15%
1 year ago
Sep 11, 2023
Financial Gravity Asset Management Inc. Purchases Shares of 129 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Defense World
Zimmer Biomet
BTIG
139 USD
Upside 28%
1 year ago
Sep 11, 2023
Axa S.A. Trims Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Defense World
Unknown Analyst
Truist Financial
137 USD
Upside 26%
1 year ago
Feb 6, 2023
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $137
Benzinga
Unknown Analyst
Morgan Stanley
140 USD
Upside 29%
1 year ago
Feb 6, 2023
Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $140
Benzinga
Show More Price Targets
Show Less Price Targets
Steven Lichtman
Oppenheimer
Price Target 135 USD
Upside/Downside 25%
View Source
Ryan Zimmerman
BTIG
Price Target 126 USD
Upside/Downside 16%
View Source
Vijay Kumar
Evercore ISI
Price Target 110 USD
Upside/Downside 1%
View Source
Richard Newitter
Truist Financial
Price Target 112 USD
Upside/Downside 3%
View Source
Caitlin Cronin
Canaccord Genuity
Price Target 115 USD
Upside/Downside 6%
View Source
Steven Lichtman
Oppenheimer
Price Target 145 USD
Upside/Downside 34%
View Source
Jayson Bedford
Raymond James
Price Target 128 USD
Upside/Downside 18%
View Source
Rick Wise
Stifel Nicolaus
Price Target 130 USD
Upside/Downside 20%
View Source
Drew Ranieri
Morgan Stanley
Price Target 120 USD
Upside/Downside 11%
View Source
Matt O'Brien
Piper Sandler
Price Target 115 USD
Upside/Downside 6%
View Source
Matthew O\'Brien
Piper Sandler
Price Target 140 USD
Upside/Downside 29%
View Source
Shagun Singh
RBC Capital
Price Target 140 USD
Upside/Downside 29%
View Source
Ryan Zimmerman
BTIG
Price Target 139 USD
Upside/Downside 28%
View Source
David Toung
Argus Research
Price Target 150 USD
Upside/Downside 38%
View Source
Zimmer Biomet
Stifel Nicolaus
Price Target 165 USD
Upside/Downside 52%
View Source
Zimmer Biomet
Truist Financial
Price Target 148 USD
Upside/Downside 37%
View Source
Zimmer Biomet
UBS
Price Target 125 USD
Upside/Downside 15%
View Source
Zimmer Biomet
BTIG
Price Target 139 USD
Upside/Downside 28%
View Source
Unknown Analyst
Truist Financial
Price Target 137 USD
Upside/Downside 26%
View Source
Unknown Analyst
Morgan Stanley
Price Target 140 USD
Upside/Downside 29%
View Source
Show More Price Targets
Show Less Price Targets
Zimmer Biomet Holdings Inc Competitors:
Price Targets
LNSR
LENSAR Inc
39% Upside
NYXH
Nyxoah SA
64% Upside
INGN
Inogen Inc
13% Upside
MEDI
Medistim ASA
26% Upside
GN
GN Store Nord A/S
61% Upside
SENS
Senseonics Holdings Inc
324% Upside
GEHC
GE Healthcare Technologies Inc
13% Upside
7716
Nakanishi Inc
18% Upside

Revenue
Forecast

Revenue Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's revenue is 3%. The projected CAGR for the next 3 years is 5%.

3%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's operating income is 2%. The projected CAGR for the next 3 years is 19%.

2%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Net Income
Forecast

Net Income Estimate
Zimmer Biomet Holdings Inc

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's net income is 27%. The projected CAGR for the next 3 years is 23%.

27%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-74%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZBH's stock price target?
Price Target
125.78 USD

According to Wall Street analysts, the average 1-year price target for ZBH is 125.78 USD with a low forecast of 108.07 USD and a high forecast of 152.25 USD.

What is Zimmer Biomet Holdings Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's revenue is 3%. The projected CAGR for the next 3 years is 5%.

What is Zimmer Biomet Holdings Inc's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's operating income is 2%. The projected CAGR for the next 3 years is 19%.

What is Zimmer Biomet Holdings Inc's Net Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Zimmer Biomet Holdings Inc's net income is 27%. The projected CAGR for the next 3 years is 23%.

Back to Top